Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old

Completed · Phase 1/Phase 2

Conditions studied: Influenza

In brief

To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age

Key facts

Study ID

NCT02035696

Run by

Seqirus

People needed

671

Starts

2013-12-01

Expected to finish

2014-12-01

Last updated by the study team

2018-07-10

Who can join

Age: 1 and older, up to 4. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subject, male or female, 6 through < 48 months of age at the time of enrollment, who has never previously received an influenza vaccine
• Individual who has a parent or guardian that can give written informed consent after understanding the nature of the study and are available for follow-up

You may not qualify if…

• Individuals recently vaccinated against influenza
• Subjects with contraindications to receive influenza vaccine

Where it is running

• Site 116 — Phoenix, Arizona, United States
• Site 119 — Tucson, Arizona, United States
• Site 109 — Little Rock, Arkansas, United States
• Site 112 — Long Beach, California, United States
• Site 113 — Ontario, California, United States
• Site 117 — San Diego, California, United States
• Site 114 — West Covina, California, United States
• Site 107 — Thornton, Colorado, United States
• Site 111 — Miami, Florida, United States
• Site 108 — Miami Beach, Florida, United States
• Site 121 — Gainesville, Georgia, United States
• Site 101 — Omaha, Nebraska, United States
• Site 104 — Omaha, Nebraska, United States
• Site 105 — Omaha, Nebraska, United States
• Site 106 — Omaha, Nebraska, United States
• Site 103 — Youngstown, Ohio, United States
• Site 102 — Charleston, South Carolina, United States
• Site 115 — Houston, Texas, United States
• Site 110 — Salt Lake City, Utah, United States
• Site 118 — St. George, Utah, United States
• Site 120 — Spokane, Washington, United States
• Site 502 — Kuopio, Finland
• Site 506 — Tampere, Finland
• Site 302 — City of Muntinlupa, Philippines
• Site 301 — Manila, Philippines

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.